26 related articles for article (PubMed ID: 1968323)
1. Electrochemical screening of selected β-blockers at a polarized liquid-liquid interface.
Sobczak K; Rudnicki K; Poltorak L
Analyst; 2024 Apr; 149(8):2363-2373. PubMed ID: 38454902
[TBL] [Abstract][Full Text] [Related]
2. Nebivolol: haemodynamic effects and clinical significance of combined beta-blockade and nitric oxide release.
Kamp O; Metra M; Bugatti S; Bettari L; Dei Cas A; Petrini N; Dei Cas L
Drugs; 2010; 70(1):41-56. PubMed ID: 20030424
[TBL] [Abstract][Full Text] [Related]
3. Nebivolol in the management of essential hypertension: a review.
McNeely W; Goa KL
Drugs; 1999 Apr; 57(4):633-51. PubMed ID: 10235696
[TBL] [Abstract][Full Text] [Related]
4. Reliability of blood pressure determination with the Finapres with altered physiological states or pharmacodynamic conditions.
McAuley D; Silke B; Farrell S
Clin Auton Res; 1997 Aug; 7(4):179-84. PubMed ID: 9292243
[TBL] [Abstract][Full Text] [Related]
5. Subacute hemodynamic effects of nebivolol in man at rest and during exercise.
De Crée J; Geukens H; Cobo C; Verhaegen H
Angiology; 1987 Jun; 38(6):440-8. PubMed ID: 2884904
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological and hemodynamic profile of nebivolol, a chemically novel, potent, and selective beta 1-adrenergic antagonist.
Van de Water A; Janssens W; Van Neuten J; Xhonneux R; De Cree J; Verhaegen H; Reneman RS; Janssen PA
J Cardiovasc Pharmacol; 1988 May; 11(5):552-63. PubMed ID: 2455841
[TBL] [Abstract][Full Text] [Related]
7. Exercise tolerance with nebivolol and atenolol.
Van Bortel LM; van Baak MA
Cardiovasc Drugs Ther; 1992 Jun; 6(3):239-47. PubMed ID: 1353367
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic effects of nebivolol in men: comparison of radionuclide angiocardiography with systolic time intervals.
De Crée J; Franken P; Vandevivere J; Geukens H; Verhaegen H
Angiology; 1988 Jun; 39(6):526-34. PubMed ID: 2897813
[TBL] [Abstract][Full Text] [Related]
9. Effects of nebivolol, atenolol and propranolol on in vivo cardiovascular and metabolic responses to isoproterenol in dogs.
Bowden CR; Marchione CS
J Pharmacol Exp Ther; 1989 Nov; 251(2):599-605. PubMed ID: 2572694
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the subacute hemodynamic effects of atenolol, propranolol, pindolol, and nebivolol.
De Crée J; Cobo C; Geukens H; Verhaegen H
Angiology; 1990 Feb; 41(2):95-105. PubMed ID: 1968323
[TBL] [Abstract][Full Text] [Related]
11. Pharmacology of nebivolol.
Mangrella M; Rossi F; Fici F; Rossi F
Pharmacol Res; 1998 Dec; 38(6):419-31. PubMed ID: 9990650
[TBL] [Abstract][Full Text] [Related]
12. Metabolic effects and safety profile of nebivolol.
Pessina AC
J Cardiovasc Pharmacol; 2001 Dec; 38 Suppl 3():S33-5. PubMed ID: 11811391
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
